p300 Alters Keratinocyte Cell Growth and Differentiation through Regulation of p21Waf1/CIP1

被引:31
|
作者
Wong, Ping-Pui [1 ]
Pickard, Adam [1 ]
McCance, Dennis J. [1 ]
机构
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
来源
PLOS ONE | 2010年 / 5卷 / 01期
基金
英国医学研究理事会;
关键词
GENE-EXPRESSION; UP-REGULATION; DNA-BINDING; IN-VIVO; CYCLE; P53; TRANSCRIPTION; CDK; ACETYLATION; PROTEIN;
D O I
10.1371/journal.pone.0008369
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: p300 functions as a transcriptional co-activator to regulate many cellular responses such as cell growth, transformation, development and differentiation. It has been shown to affect the transcriptional activity of p53 which regulates p21(Waf1/CIP1) expression, however, the role of p300 in differentiation remains unclear. Methodology and Principal Findings: Knockdown of p300 protein with short hairpin RNA (shRNA) molecules delays human neonatal foreskin keratinocyte (HFKs) differentiation. Moreover, depletion of p300 increases the proliferative capacity of HFKs, extends the life span of cells and allows differentiated HFKs to re-enter the cell cycle. Studies indicate that depletion of p300 down-regulates the acetylation and expression of p53, and chromatin immunoprecipitation (ChIP) analysis shows that induction of p21(Waf1/CIP1) in early differentiation is a result of p300 dependent activation of p53 and that depletion of p21(Waf1/CIP1) results in the delay of differentiation and a phenotype similar to p300 depletion. Conclusions: p300 has a direct role in the control of cell growth and differentiation in primary epithelial cells, and p21(Waf1/CIP1) is an important mediator of these p300 functions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer
    Zohny, Samir F.
    Al-Malki, Abdulrahman L.
    Zamzami, Mazin A.
    Choudhry, Hani
    BREAST CANCER, 2019, 26 (02) : 131 - 137
  • [2] POST-TRANSCRIPTIONAL REGULATION OF P21WAF1/CIP1 BY P53
    季加孚
    张霁
    焦春雨
    顾晋
    谭立新
    张平
    李培详
    Chinese Journal of Cancer Research, 2001, (02) : 35 - 39
  • [3] p21WAF1/CIP1 and cancer: A shifting paradigm?
    Gartel, Andrei L.
    BIOFACTORS, 2009, 35 (02) : 161 - 164
  • [4] YueF Overexpression Inhibits Cell Proliferation Partly through p21WAF1/Cip1 Upregulation in Renal Cell Carcinoma
    Huang, Hsuan-Wei
    Peng, Jian-Ping
    Zhang, Jie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (04) : 2477 - 2487
  • [5] p21WAF1/Cip1 - PCNA: Fatal attraction
    Galanos, Panagiotis
    Pappas, George
    Gorgoulis, Vassilis G.
    CELL CYCLE, 2016, 15 (23) : 3153 - 3154
  • [6] p21WAF1/Cip1:: more than a break to the cell cycle?
    Dotto, GP
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1471 (01): : M43 - M56
  • [7] p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer
    Samir F. Zohny
    Abdulrahman L. Al-Malki
    Mazin A. Zamzami
    Hani Choudhry
    Breast Cancer, 2019, 26 : 131 - 137
  • [8] BCCIP Functions through p53 to regulate the expression of p21Waf1/Cip1
    Meng, XB
    Lu, HM
    Shen, ZY
    CELL CYCLE, 2004, 3 (11) : 1457 - 1462
  • [9] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    De la Cueva, E.
    Garcia-Cao, I.
    Herranz, M.
    Lopez, P.
    Garcia-Palencia, P.
    Flores, J. M.
    Serrano, M.
    Fernandez-Piqueras, J.
    Martin-Caballero, J.
    ONCOGENE, 2006, 25 (29) : 4128 - 4132
  • [10] Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma
    E De la Cueva
    I García-Cao
    M Herranz
    P López
    P García-Palencia
    J M Flores
    M Serrano
    J Fernández-Piqueras
    J Martín-Caballero
    Oncogene, 2006, 25 : 4128 - 4132